U.S. Metastatic Prostate Cancer Diagnoses Increase After Reduction in PSA Screening April 30, 2021 A reduction in prostate-specific antigen (PSA) screening in men aged 40 years and older was associated with an increase in metastatic prostate cancer diagnoses in the United States, according to results of a study presented at the 2021 ASCO Genitourinary Cancers Symposium.Between 2008 and 2016, across all states, the mean percentage of men undergoing PSA screening decreased from 61.8% to 50.5%, while the mean incidence of metastatic prostate cancer at diagnosis increased from 6.4 to 9.0 per 100,000 (adjusted P<0.001 for both) (abstract 228).Read the full article here. source: Clinical Oncology Read More About Prostate Cancer Enjoy our library of additional news articles, our Journey to ZERO blog, and our ZEROHour newsletter. ZERO in the News ZERO in the News Read features about ZERO Prostate Cancer in the news—covering events, personal stories, advocacy efforts, and more! ZEROHour ZEROHour ZEROHour features news about prostate cancer, updates on ZERO’s initiatives and activities, and featured stories of those impacted by the disease. Journey to ZERO Journey to ZERO Our Journey to ZERO blog features commentary and discussion about what's happening in the prostate cancer community, stories and inspiration from people impacted by the disease, and insights on news and current events. About Prostate Cancer Prostate Cancer News Research More for you
A reduction in prostate-specific antigen (PSA) screening in men aged 40 years and older was associated with an increase in metastatic prostate cancer diagnoses in the United States, according to results of a study presented at the 2021 ASCO Genitourinary Cancers Symposium.Between 2008 and 2016, across all states, the mean percentage of men undergoing PSA screening decreased from 61.8% to 50.5%, while the mean incidence of metastatic prostate cancer at diagnosis increased from 6.4 to 9.0 per 100,000 (adjusted P<0.001 for both) (abstract 228).Read the full article here. source: Clinical Oncology
Read More About Prostate Cancer Enjoy our library of additional news articles, our Journey to ZERO blog, and our ZEROHour newsletter. ZERO in the News ZERO in the News Read features about ZERO Prostate Cancer in the news—covering events, personal stories, advocacy efforts, and more! ZEROHour ZEROHour ZEROHour features news about prostate cancer, updates on ZERO’s initiatives and activities, and featured stories of those impacted by the disease. Journey to ZERO Journey to ZERO Our Journey to ZERO blog features commentary and discussion about what's happening in the prostate cancer community, stories and inspiration from people impacted by the disease, and insights on news and current events.
